Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents

Anibamine produces significant inhibition of prostate cancer cell proliferation at micromolar to submicromolar concentrations and inhibits prostate tumor growth in mice.